The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
- Digital Object Identifier
- https://doi.org/10.1002/jha2.805
- Open Access
- http://aura.abdn.ac.uk/bitstreams/788786c6-7e54-4578-8cd2-d4b3a5c11786/download